checkAd

    EQS-Adhoc  664  0 Kommentare Cytos Biotechnology AG: Trading of Cytos shares and convertible bonds temporarily suspended.


    EQS Group-Ad-hoc: Cytos Biotechnology AG / Key word(s): Miscellaneous
    Cytos Biotechnology AG: Trading of Cytos shares and convertible bonds
    temporarily suspended.

    26.01.2015 / 07:00
    Release of an ad hoc announcement pursuant to Art. 53 KR.
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------

    Cytos Biotechnology Ltd holds a Bondholders' meeting today. Trading of
    Cytos shares and convertible bonds temporarily suspended.

    Schlieren (Zurich), Switzerland, 26 January 2015, - Cytos Biotechnology Ltd
    (SIX:"CYTN"; the "Company") holds today a meeting of the Bondholders to
    vote on the restructuring proposal for the convertible bonds, as announced
    on 6 January 2015. As the outcome of the meeting is unknown und such
    outcome may be price sensitive, Cytos has applied with the SIX Swiss
    Exchange to suspend trading of Cytos' shares as well as Cytos' convertible
    bonds from ten minutes prior to the start of the meeting (i.e. 12.50 CET)
    until at least one hour after the outcome of the meeting has been
    communicated by Cytos in a media release. The SIX Swiss Exchange has
    approved this request.

    For further information, please contact:

    Cytos Biotechnology Ltd
    Harry Welten, MBA
    Chief Financial Officer
    Tel: +41 44 733 46 46
    harry.welten@cytos.com

    About Cytos Biotechnology Ltd

    Cytos is a public biopharmaceutical company located in Schlieren (Zurich),
    Switzerland. The Company is listed according to the Main Standard on the
    SIX Swiss Exchange Ltd under the symbol CYTN.

    Forward Looking Statements
    This media release contains certain forward-looking statements that involve
    risks and uncertainties that could cause actual results to be materially
    different from historical results or from any future results expressed or
    implied by such forward-looking statements. You are urged to consider
    statements that include the words "will" or "expect" or the negative of
    those words or other similar words to be uncertain and forward-looking.
    Factors that may cause actual results to differ materially from any future
    results expressed or implied by any forward-looking statements include
    scientific, business, economic and financial factors, Against the
    background of these uncertainties, readers should not rely on
    forward-looking statements. The Company assumes no responsibility for
    updating forward-looking statements or adapting them to future events or
    developments.

    www.cytos.com

    End of ad hoc announcement

    +++++
    Additional features:

    Document: http://n.equitystory.com/c/fncls.ssp?u=KTKONWJAXQ
    Document title: Cytos_Press_E_150126

    ---------------------------------------------------------------------

    26.01.2015 News transmitted by EQS Schweiz AG. www.eqs.com - news
    archive: http://switzerland.eqs.com/de/News

    The issuer is responsible for the contents of the release.

    ---------------------------------------------------------------------


    Language: English
    Company: Cytos Biotechnology AG
    Wagistr. 25
    8952 Schlieren
    Switzerland
    Phone: +41 44 733 4747
    Fax: +41 44 733 4740
    E-mail: info@cytos.com
    Internet: www.cytos.com
    ISIN: CH0011025217, CH0029060735
    Valor: -
    Listed: Freiverkehr in Berlin, München, Stuttgart; Frankfurt in
    Open Market ; SIX


    End of News EQS Group News-Service
    ---------------------------------------------------------------------
    316091 26.01.2015


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Cytos Biotechnology AG: Trading of Cytos shares and convertible bonds temporarily suspended. EQS Group-Ad-hoc: Cytos Biotechnology AG / Key word(s): Miscellaneous Cytos Biotechnology AG: Trading of Cytos shares and convertible bonds temporarily suspended. 26.01.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The …

    Schreibe Deinen Kommentar

    Disclaimer